Navigation Links
Delcath Continues Expansion of Clinical Trial Centers Offering PHP(TM)
Date:4/9/2009

stated, "We are delighted to have Ohio State and Dr. Bloomston join this trial as we continue to expand to an increasing number of leading cancer centers in the United States. The prestige of these centers is a validation of the need for a viable treatment option for these very ill patients. Continuing to expand this trial assists in the acceleration of enrollment, increases the awareness of the Delcath PHP System(TM) among physicians, and expands patient access to PHP(TM)."

About The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute

The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute is one of only 40 NCI-designated Comprehensive Cancer Centers in the United States and the only freestanding cancer hospital in the Midwest. Ranked among the top 20 cancer hospitals in the nation, The James is the 172-bed adult patient-care component of the cancer program at The Ohio State University. For more information, visit www.jamesline.com.

About Delcath Systems, Inc.

Delcath Systems, Inc. is a medical technology company specializing in cancer treatment. The Company is testing a proprietary, patented drug delivery system for the treatment of liver cancers. Delcath's novel drug delivery platform is testing the delivery of ultra-high doses of anti-cancer drugs to the liver while preventing these high doses of drug from entering the patient's bloodstream. The Company is currently enrolling patients in Phase III and Phase II clinical studies for the treatment of liver cancers using high doses of melphalan. The Company's intellectual property portfolio consists of twenty-seven patents on a worldwide basis including the U.S., Europe, Asia and Can
'/>"/>

SOURCE Delcath Systems, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Delcath Adds Dr. Pamela R. Contag to Its Board of Directors
2. Delcath Expands Phase III Trial for Metastatic Melanoma to Include St. Lukes Cancer Center
3. Delcath Updates Phase III Patient Enrollment as Pivotal Trial Accelerates, Durable Tumor Responses In Phase II Study Also Cited
4. Delcath Expands Phase III Trial for Metastatic Melanoma to Include University of Maryland Medical Center
5. Vantia Therapeutics Pipeline Continues to Mature
6. Update of Long-Term Data on Brain Cancer Patients Receiving DCVax(R)-Brain Continues to Show Striking Improvements in Delay of Disease and Survival
7. ACORN Continues Success in Oncology Data Warehousing With Accumulation of Nearly 50 Million Data Observations
8. AlphaVax Continues to Expand the Use of Its Vaccine Platform
9. Replidyne Discontinues Phase III Trial
10. Update From Mipomersen Extended Dosing Study Continues to Show That Mipomersen Is Well Tolerated and Maintains Activity in Patients Treated for Up to 16 Months
11. Medarex Announces Ipilimumab Program Continues to Move Forward
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2015)... , April 20, 2015 Actavis plc ... Charles M. Mayr , Chief Communications Officer, will ... health reasons.  In conjunction with Mayr,s retirement, ... the role of Chief Communications Officer, effective immediately. ... as Senior Vice President, Chief Communications Officer, Public ...
(Date:4/20/2015)... , April 20, 2015 Merrimack ... final clinical results for the Phase 1 study ... HER2-positive metastatic breast cancer.  The results were presented ... trials plenary oral session at the 2015 American ... Philadelphia, PA. Data described ...
(Date:4/20/2015)... -- This report analyzes the worldwide markets for Medical ... provides separate comprehensive analytics for the US, ... Rest of World. Annual estimates and forecasts are provided ... historic analysis is provided for these markets. Market data ... Company profiles are primarily based on public domain information ...
Breaking Medicine Technology:Actavis Announces Retirement of Charles M. Mayr 2Actavis Announces Retirement of Charles M. Mayr 3Merrimack Announces Final Clinical Results for MM-302 Phase 1 Study Demonstrating Robust Activity in Heavily Pre-Treated Patients with HER2-Positive Metastatic Breast Cancer 2Merrimack Announces Final Clinical Results for MM-302 Phase 1 Study Demonstrating Robust Activity in Heavily Pre-Treated Patients with HER2-Positive Metastatic Breast Cancer 3Merrimack Announces Final Clinical Results for MM-302 Phase 1 Study Demonstrating Robust Activity in Heavily Pre-Treated Patients with HER2-Positive Metastatic Breast Cancer 4Merrimack Announces Final Clinical Results for MM-302 Phase 1 Study Demonstrating Robust Activity in Heavily Pre-Treated Patients with HER2-Positive Metastatic Breast Cancer 5World Medical Equipment Rental and Leasing Industry 2World Medical Equipment Rental and Leasing Industry 3World Medical Equipment Rental and Leasing Industry 4World Medical Equipment Rental and Leasing Industry 5World Medical Equipment Rental and Leasing Industry 6World Medical Equipment Rental and Leasing Industry 7
... Oct. 6 MedInformatix , a leading provider ... PhoneTree , a developer and manufacturer of automated telecommunication ... at integrating MedInformatix, Electronic Medical Records (EMR) ... PhoneTree Patient Messaging ™.  The combined solutions, now ...
... NASHVILLE, Tenn. and GLEN ROCK, N.J., Oct. 6 ... rising costs of asthma and chronic obstructive pulmonary disease ... their formularies. According to the report entitled Formulary ... surveyed pharmacy directors expect asthma and COPD drug prices ...
Cached Medicine Technology:MedInformatix, PhoneTree Integrate Health Practice Products Via New Partnership 2MedInformatix, PhoneTree Integrate Health Practice Products Via New Partnership 3Due to Rising Costs of Asthma and Chronic Obstructive Pulmonary Disease Drugs, Managed Care Organization Pharmacy Directors Will be Forced to Tighten Their Formularies 2
(Date:4/21/2015)... NC (PRWEB) April 21, 2015 A ... survival rates among patients with peritoneal cancers like mesothelioma ... Surviving Mesothelioma has just posted the results of the ... . , Doctors at North Hampshire Hospital in ... with peritoneal malignancies such as mesothelioma between ...
(Date:4/21/2015)... April 21, 2015 Atlantic Information ... launch of Medicare-Medicaid Dual Eligibles Database, a brand-new, ... care provided to the more than 9 million ... for more than $300 billion in annual health ... the same team that also creates the industry-leading ...
(Date:4/21/2015)... Now, busy Diet Doc clients can bolster their metabolism ... breakfast omelets. Like Diet Doc’s other pre-packaged diet meals, ... are delivered directly to their door. Patients can choose from ... only appeal to the taste buds, but ensure that dieters ... low carbohydrate meals. , One of the only medical ...
(Date:4/21/2015)... TX (PRWEB) April 21, 2015 ... is actively involved in various components of breast ... fields. , "Breast reconstruction research continues ... mastectomy. Despite recent advances, many unanswered questions ... provide patients with optimal results," says Dr. Oscar ...
(Date:4/21/2015)... April 21, 2015 The Science Museum of ... special addition to its Lunch Break Science program. On Wednesday, ... Quarks! – taking guests from the subatomic world of quantum ... The Museum invites members of the community to grab lunch ... Lab physicist. Guests will delve into the nucleus and dissect ...
Breaking Medicine News(10 mins):Health News:New Findings Highlight Value of Experience in Peritoneal Mesothelioma Treatment, According to Surviving Mesothelioma 2Health News:New AIS Database Tracks All Programs, Plans Serving the Dual-Eligible Community 2Health News:Diet Doc Makes Dieting for People on the Go Easier than ever before with Pre-Packaged Diet Meals, Desserts, Snacks and new Breakfast Omelets 2Health News:Diet Doc Makes Dieting for People on the Go Easier than ever before with Pre-Packaged Diet Meals, Desserts, Snacks and new Breakfast Omelets 3Health News:Diet Doc Makes Dieting for People on the Go Easier than ever before with Pre-Packaged Diet Meals, Desserts, Snacks and new Breakfast Omelets 4Health News:Research Performed at PRMA Expands Breast Reconstruction Knowledge 2Health News:Research Performed at PRMA Expands Breast Reconstruction Knowledge 3Health News:Research Performed at PRMA Expands Breast Reconstruction Knowledge 4Health News:Research Performed at PRMA Expands Breast Reconstruction Knowledge 5Health News:Quarks and Forks at the Science Museum of Virginia 2
... likely to bear an underweight child, but some women ... genetic susceptibility.// The finding could help medicine better determine ... said they were not recommending at this point that ... ,"Our data demonstrate that a subgroup of ...
... the UK’s biggest killer, accounting for one in four ... key issue is that the diversity of lung disease ... have specialists who deal only in one disorder, chest ... obstructive pulmonary disorder(COPD), asthma, pneumonia, cystic fibrosis and sleep ...
... found that butterbur extract is an effective antihistamine without ... contains an active biochemical agent,// otherwise it would not ... might react with other medications. ,It was ... patients either butterbur extract tablets or the usually used ...
... Millions of Americans have been drinking tap water contaminated ... to disinfect drinking water.// When it is added to ... farms or lawns, however, it can form compounds such ... study released by the Environmental Working Group and Public ...
... save 40,000 more lives each year worldwide if more people ... took it, doctors said.// An analysis of nearly 300 ... to prevent blood clots confirmed that aspirin reduces heart attacks ... the people who could benefit from aspirin and anti-platelet therapy ...
... has launched Hyalosyn (sodium hyaluronate), an intra-articular injection that ... suffering from severe osteoarthritis. Osteoarthritis is a widely prevalent ... the age of 45 are estimated to show signs ... of disability in people above the age of 65. ...
Cached Medicine News:
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: